Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 19/Aug 19:32
Microtome Market worth $585 million by 2027 – Exclusive Report by MarketsandMarkets™
North America region, the microtome market is devided into US and cananda. US is expected to dominate the market. The high prevalence of cancer, coupled with the increasing demand for
Articles similaires
Insulin Delivery Devices Market worth $46.2 billion by 2028 | MarketsandMarkets
In the near future, the insulin delivery devices industry is poised for remarkable advancements that promise to revolutionize diabetes management....
Nuclear Medicine/Radiopharmaceuticals Market worth $9.4 billion by 2028 | MarketsandMarkets
The nuclear medicine industry is poised for significant growth in the near future, driven by the increasing incidence of cancer and chronic diseases...
Continuous Renal Replacement Therapy Market worth $2.1 billion by 2028| MarketsandMarkets
The key players in the continuous renal replacement therapy market Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US)...
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Les derniers communiqués
-
Aucun élément